Koru Medical (KRMD) announced the appointment of Eric Schiller as Chief Technology Officer, effective December 29, 2025. Eric joins KORU Medical with more than 25 years of leadership experience across research & development, device engineering, drug-device combination product development, supply chain strategy, and end-to-end product lifecycle management. As Chief Technology Officer, Eric will lead KORU’s product development and innovation pipeline and help shape the Company’s long-term technology and platform strategy, leveraging his experience to integrate portfolio planning with the evolving needs of KORU’s growing global customer base. He most recently served as Global Head of Device Development Portfolio at Sanofi.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRMD:
- REPRO-MED Systems Signs New Manufacturing Agreement
- Repro-Med Systems’ Earnings Call Highlights Growth and Challenges
- Koru Medical price target raised to $6.25 from $6 at Craig-Hallum
- Strong Revenue Growth and Strategic Positioning Drive Buy Rating for REPRO-MED Systems
- KORU Medical Systems Reports Strong Q3 Growth